Michael John Tomsicek, Chief Financial Officer at CRISPR Therapeutics AG (CRSP), sold 50,000 shares at $138.22 ($6.9M) on 2021-08-06, disclosed to the SEC on 2021-08-10.
Open-market sale of $6.9M CRSP by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.22 | 19,011 | $2.6M | 37.9% |
| 2 | $138.22 | 19,011 | $2.6M | 37.9% |
| 3 | $139.46 | 5,989 | $835K | 12.1% |
| 4 | $139.46 | 5,989 | $835K | 12.1% |
| Total | $138.52 avg | 50,000 | $6.9M | 100% |
| Filing → |
| CRSP | SELL | 2020-08-05 | $1.5M | — | Filing → |
| CBST | SELL | 2014-08-18 | $26K | — | Filing → |
| CBST | SELL | 2014-05-14 | $34K | — | Filing → |